• Horak, F., Jäger, S., Toth J. (1993). Klinische Reflexionen zur Aggressivitätssteigerung der Birkenpollen. Atemwegs- und Lungenkrankheiten. (1. Supplementärheft), München-Deisenhofen: Dustri-Verlag.

  • Horak, F., Toth, J., Jäger, S., Berger, U. (1993). Effects of H1-receptor antagonists on nasal obstruction in atopic patients. Allergy, 48(4), 226-229.

  • Horak, F., Jäger, S., Toth, J., Berger, U., Nirnberger, E. (1994). Azelastine in pollen-induced allergic rhinitis: A pharmacodynamic study of onset of action and efficacy. Drug Invest, 7(1), 34-40.

  • Horak, F., Jäger, S., Toth, J., Berger, U., Nirnberger, G., Kyrein, H.J., Vix, J.M. (1994). Controlled exposure to mite allergen for a dose-finding of dimethindene maleate (DMM). Agents Actions, 124-126.

  • Horak, F., Jäger, S., Toth, J., & Berger, U. (1996). Efficacy and tolerability of astemizole-D and Loratadine-D during prolonged, controlled allergen challenge in the Vienna Challenge Chamber. Arzneimittelforschung, 46(11), 1077-1081.

  • Füreder, W., Bankl, H.C., Toth, J., Walchshofer, S., Sperr, W., Agis, H., Semper, H., Sillaber, C., Lechner, K., Valent, P. (1997). Immunophenotypic and functional characterization of human tonsillar mast cells. Journal of Leukocyte Biology, 61(5), 592-599.

  • Temmel, A., Toth, J., Marks, B., Jäger, S., Berger, U., Reiser, K., Horak, F. (1998). Rhinoresistometry versus rhinomanometry–an evaluation. Klin Wochenschr, 110(17), 612-615.

  • Toth, J., Schultze-Werninghaus, C., Marks, B., Temmel, A. (1998). Environmental priming influences allergen-specific nasal reactivity. Allergy, 53(12), 1172-1177.

  • Horak, F., Toth, J., Hirschwehr, R., Marks B., Stübner U.P., Jäger S., Berger U., Schleinzer, K., Günczler, P. (1998). Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. Allergy, 53(1), 68-72.

  • Horak, F., Toth J., Marks, B., Stübner, U.P., Berger, U.E., Jäger, S., Burtin, B., Duby C. (1998). Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy, 53(9), 849-856.

  • Horak, F., Stübner, P., Berger U.E., Marks, B., Toth, J., Jäger, S. (1998). Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. Investig Allergol Clin Immunol, 8(3), 165-71.

  • Horak, F., Berger, U.E., Menapace, R., Toth, J., Stübner, P.U., Marks, B. (1998). Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study. Arzneimittelforschung. 48(4), 379-384.

  • Temmel, A.F., Quint, C., Toth, J., Herneth, A., Hummel, T. (1999). Topical ephedrine administration and nasal chemosensory function in healthy human subjects. Arch Otolaryngol Head Neck Surg, 125(9), 1012-1014.

  • Kornek, V., Scheithauer, W., Glaser, C., Toth, J., Duman, M., Formanek, M., Hejna, M., Kornfehl, J. (1999). Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Oncology, 56(1), 24-27.

  • Stübner, U.P., Gruber, D., Berger, U.E., Toth, J., Marks, B., Huber, J., Horak, F. (1999). The influence of female sex hormones on nasal reactivity in seasonal allergic rhinitis. Allergy, 54(8), 865-871.

  • Temmel, A.F., Herbst, T., Popovic, R., Toth, J., Marks, B., Horak, F., Kautzky, M., Steurer, M. (2000). Upper airway findings in patients with nocturnal breathing disorders. Klin Wochenschr, 112(17), 767-771.

  • Stübner, U.P., Toth, J., Marks, B., Berger, U.E., Burtin, B., Horak, F. (2001). Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittelforschung, 51(11), 904-910.

  • Toth, J., Temmel, A.F. (2004). Medikamentöse Therapie der Riechstörungen. Laryngo-Rhinol-Otol, 83, 124-132.

  • Zieglmayer, U.P., Horak, F., Toth, J., Marks, B., Berger, U.E., Burtin, B. (2005). Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis. Treat Respir Med., 4(4), 283-287.

  • Müller, C., Temmel, A.F., Toth, J., Quint, C., Herneth, A., Hummel, T. (2006). Computed tomography scans in the evaluation of patients with olfactory dysfunction. Am J Rhinol, 20(1), 109-112.